|
Clinical trials are now recruiting patients for the new Merck drug VX-680
which has been developed to work on the T315I mutation. There are 3 separate
trials that are now open with trial locations in Texas, Massachusetts, New
Jersey, Pennsylvania, and Wisconsin. CML patients who have failed
on Gleevec, AMN107, and BMS354825 may be eligible for this trial.
This is a potentially a very important drug for CML patients because it may
work on the T315I mutation. If you know of any CML patients with the T315I
mutation let them know about these trial locations so can find out if they may
be eligible.
New! Sign up for local CML support group meetings in your local community at http://cml.meetup.com Apply for Commercial Real Estate loans online and submit your deal to dozens of hungry lenders in just minutes. Loan programs for all types of business and commercial real estate. Apply anytime at http://realestatezoo.com CML (Chronic Myelogenous Leukemia Support List) --------------------------------- Part Of CMLHope.Com An International Community Of CML Patients For more information: http://cmlhope.com Post Message: [email protected] Subscribe: [EMAIL PROTECTED] Unsubscribe: [EMAIL PROTECTED] Change To No Mail/Web: [EMAIL PROTECTED] Change To Digest: [EMAIL PROTECTED] Change To Email: [EMAIL PROTECTED] List Help: [EMAIL PROTECTED] CML Group Web Site http://groups.yahoo.com/group/CML YAHOO! GROUPS LINKS
|
